Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Health Affairs: More light shed on healthcare reform's day in Supreme Court

The Supreme Court is filling its entire court calendar the week of March 26 with arguments relating to the impending review of the constitutionality of the Patient Protection and Affordable Care Act (PPACA); totaling five and a half hours over three days with a decision expected in late June.

OIG: Only 14% of patient harm events are reported

Despite federal regulations requiring hospitals participating in Medicare to develop and maintain Quality Assessment and Performance Improvement programs, hospital incident reporting systems only captured an estimated 14 percent of patient harm events experienced by Medicare beneficiaries discharged in October 2008, according to a January Office of Inspector General (OIG) report.

HHS proposes electronic fund transfers to reduce admin costs

The Department of Health and Human Services (HHS) issued an interim final rule with comment period where the agency will adopt standards for the HealthCare Electronic Funds Transfers and Remittance Advice transaction under HIPAA to mitigate administrative costs for providers.

AHIMA: 2012's health IT must-see list revealed

Beginning in 2009 with the American Recovery and Reinvestment Act and the decision to adopt ICD-10, federal efforts to encourage health IT implementation have formed a labyrinth of initiatives for health IT professionals to navigate, according to an article in the Journal of American Health Information Management Association.  

CMS issues 35 core healthcare quality measures

The Centers for Medicare & Medicaid Services (CMS) has finalized an initial core set of 35 healthcare quality measures for Medicaid-eligible adults as required by the Patient Protection and Affordable Care Act.

JAMA: U.S. posts shortest stays, highest MI readmission rate

In an effort to reduce healthcare costs, the U.S. has succeeded in getting the length of hospital stays for myocardial infarction (MI) down, but the tradeoff may be in higher readmission rates, according to a study that compared 30-day MI readmission rates in the U.S. and 16 other countries. The study in the Jan. 4 issue of the Journal of the American Medical Association found that patients in the U.S. had the shortest median length of stay but also had a 68 percent increased risk of being readmitted within a month.

AHRQ provides guidelines for evaluating medical homes

Patient-centered medical homes (PCMH), healthcare organizations that employ a coordinated delivery model designed to provide cost-effective care, are emerging as efforts to cure the fragmented nature of the healthcare system. However, there are few standards to guide evaluations of PCMHs' effectiveness, which has prompted the Agency for Healthcare Research and Quality (AHRQ) to make PCMH evaluation recommendations.

Developing the Oncology Service Line: What Providers Should Know

Demand for oncology services is on the rise, and that has hospitals around the country looking at either adding a new or bolstering an existing oncology service line, says Timea Zsiray, oncology marketing manager for GE Healthcare (Waukesha, Wisconsin). “The Journal of Clinical Oncology projected that by 2030 there will be a 45% increase in cancer

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.